Previous 10 | Next 10 |
Members of the Sackler family who own Purdue Pharma raised their settlement offer in ongoing opioid litigation to $4.3b from $3b, according to a Reuters report.Sackler family members are offering to contribute $4.3b to help settle thousands of lawsuits from U.S. communities that are trying to...
Endo International (ENDP) announces that its wholly-owned subsidiaries Endo Luxembourg Finance and Endo U.S. intend to offer senior secured notes.Intends to use the net proceeds from the proposed offering, together with the proceeds of a previously announced new senior secured term loan,...
Endo International plc Announces Proposed Private Offering Of Senior Secured Notes Canada NewsWire DUBLIN , March 11, 2021 /CNW/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that its wholly-owned subsidiaries Endo Luxembourg Finance Comp...
Endo International plc Commences Refinancing of its Existing Term Loan PR Newswire DUBLIN , March 4, 2021 /PRNewswire/ -- Endo International plc (NASDAQ: ENDP) ("Endo") today announced that it has commenced a refinancing of its existing $3.3 billion senior se...
John Paulson’s 13F portfolio value increased from $3.21B to $3.85B this quarter. Paulson & Company's largest three positions are Horizon Therapeutics, Bausch Health, and BrightSphere Investment Group. The stake in Barrick Gold was more than doubled during the quarter. ...
Endo International PLC (ENDP) Q4 2020 Earnings Conference Call February 26, 2021, 07:30 ET Company Participants Laure Park - SVP, IR & Corporate Affairs Blaise Coleman - President, CEO & Director Mark Bradley - EVP & CFO Patrick Barry - EVP & President, Global Commercial Opera...
The following slide deck was published by Endo International plc in conjunction with their 2020 Q4 earnings call. For further details see: Endo International plc 2020 Q4 - Results - Earnings Call Presentation
Image source: The Motley Fool. Endo International plc (NASDAQ: ENDP) Q4 2020 Earnings Call Feb 26, 2021 , 7:30 a.m. ET Operator Continue reading For further details see: Endo International plc (ENDP) Q4 2020 Earnings Call Transcript
Endo International (ENDP) posted fourth-quarter profit and revenue that beat Wall Street estimates, driven by the strength in its Sterile Injectables segment.Fourth-quarter 2020 Sterile Injectables segment revenues were $332M, an increase of 16% compared to last year.Total revenues durin...
Endo (ENDP): Q4 Non-GAAP EPS of $0.75 beats by $0.27; GAAP EPS of $0.60 beats by $0.82.Revenue of $760.22M (-0.6% Y/Y) beats by $108.81M.Press Release For further details see: Endo EPS beats by $0.27, beats on revenue
News, Short Squeeze, Breakout and More Instantly...
Endo International plc Company Name:
ENDP Stock Symbol:
NASDAQ Market:
Endo International plc Website:
Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Endo Presents New Data at the American Orthopaedic Foot & Ankle Society Annual Meeting Canada NewsWire DUBLIN , Sept. 21, 2023 /CNW/ -- Endo International plc (OTC:...
ENDO REPORTS SECOND-QUARTER 2023 FINANCIAL RESULTS Canada NewsWire DUBLIN , Aug. 8, 2023 /CNW/ -- Endo International plc (OTC: ENDPQ) today reported financial results for the second-quarter ended June 30, 2023 . SECOND-QUARTER FINANCIAL PERF...
Endo Launches PREVDUO™ (neostigmine methylsulfate and glycopyrrolate injection), the First and Only FDA-Approved Neostigmine-Glycopyrrolate Combination Pre-Filled Syringe Canada NewsWire The ready-to-use pre-filled syringe combines two well-known, FDA-approved product...